Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
06/08/2026 21:06
BRIEF-Amphastar Pharmaceuticals Q2 EPS USD 0.67 Aug 06 (Reuters) - Amphastar Pharmaceuticals Q2 revenue USD 183.903 million vs. IBES estimate USD 182.1 million.
- Q2 adjusted net income USD 40.759 million vs. IBES estimate USD 31.2 million
- Q2 adjusted EPS USD 0.91 vs. IBES estimate USD 0.62
- Q2 net income USD 30.348 million
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray